Journal
FERTILITY AND STERILITY
Volume 101, Issue 4, Pages 898-904Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2014.02.025
Keywords
Hormone therapy; cognition; mood
Categories
Funding
- NIA NIH HHS [P50 AG033514, R01 AG029624, R01 AG031790] Funding Source: Medline
Ask authors/readers for more resources
Objective: Results of the Women's Health Initiative (WHI) and Women's Health Initiative Memory Study (WHIMS) suggested that hormone therapy (HT) may be detrimental to cognitive health. This article reviews clinical studies that address issues relevant to those results. Design: Literature review. Intervention(s): A search of Pubmed and Web of Science was conducted using the search terms HT and cognition, HT and mood. Clinical and observational studies were selected if they were published after the year 2000. Theories of HT mechanisms of action, pharmacology, biology, and observational and clinical trials are discussed. Result(s): Although observational and clinical trials show conflicting findings, methodologic considerations must be acknowledged. HT formulation and dose, route of administration, timing of initiation, length of treatment, and health of participants all contribute to inconsistencies in results. Transdermal estradiol and micronized progesterone administered at time of menopause are generally associated with cognitive and affective benefit. Conclusion(s): At the present time, results from existing studies are equivocal regarding the benefits of HT on cognition and affect. Future studies, such as the Kronos Early Estrogen Prevention Study (KEEPS), should address methodologic inconsistencies to provide clearer answers to this important question. (C) 2014 by American Society for Reproductive Medicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available